Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00071955
Status:
COMPLETED
Last Update Posted:
2013-12-19
First Post:
2003-11-04
Brief Title:
Vaccine Therapy and Sargramostim After Rituximab in Treating Patients With Refractory or Progressive Non-Hodgkins Lymphoma
Sponsor:
Genitope Corporation
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
Keywords:
| Name | View |
|---|---|
| stage IV grade 3 follicular lymphoma | View |
| recurrent grade 1 follicular lymphoma | View |
| recurrent grade 2 follicular lymphoma | View |
| recurrent grade 3 follicular lymphoma | View |
| stage III grade 1 follicular lymphoma | View |
| stage III grade 2 follicular lymphoma | View |
| stage III grade 3 follicular lymphoma | View |
| stage IV grade 1 follicular lymphoma | View |
| stage IV grade 2 follicular lymphoma | View |